NeuroStar® clinical results and ongoing clinical trials

NeuroStar TMS Therapy for depression has the largest clinical data set of any TMS treatment. Clinical studies with 900 patients have shown that NeuroStar TMS Therapy can help achieve remission for patients living with depression.5, 6, 7, 8, 9

For many patients, depression symptoms significantly improved or went away after 4 to 6 weeks of treatment with NeuroStar TMS Therapy5:

  • 1 in 2 patients experienced significant improvement
  • 1 in 3 patients were symptom free

In an NIMH-funded, independent, randomized controlled trial, patients treated with TMS using the NeuroStar TMS System, were four times more likely to achieve remission compared to patients receiving sham treatment (P = 0.0173; odds ratio = 4.05).6

TMS was included in the 2010 American Psychiatric Association (APA) Practice Guideline for the Treatment of Patients with Major Depression—guidelines that provide recommendations for how psychiatrists treat depression.10

Ongoing Clinical Trials

Neuronetics continues to support clinical trial programs. The following are sponsored by Neuronetics:
Adolescent Depression Study

NeuroStar – a safe treatment for depression